Operating Lease, Liability of KalVista Pharmaceuticals, Inc. from 31 Jul 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
KalVista Pharmaceuticals, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Jul 2019 to 30 Sep 2025.
  • KalVista Pharmaceuticals, Inc. Operating Lease, Liability for the quarter ending 30 Sep 2025 was $10,557,000.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,557,000 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q1 2025 $6,307,000 -$1,010,000 -14% 30 Apr 2025 10-K 10 Jul 2025 2025 FY
Q1 2024 $7,317,000 -$915,000 -11% 30 Apr 2024 10-K 11 Jul 2024 2024 FY
Q1 2023 $8,232,000 +$44,000 +0.54% 30 Apr 2023 10-K 10 Jul 2023 2023 FY
Q1 2022 $8,188,000 +$2,279,000 +39% 30 Apr 2022 10-K 07 Jul 2022 2022 FY
Q2 2021 $7,379,000 +$5,856,000 +385% 31 Jul 2021 10-Q 09 Sep 2021 2022 Q1
Q1 2021 $5,909,000 +$4,264,000 +259% 30 Apr 2021 10-K 13 Jul 2021 2021 FY
Q4 2020 $1,715,000 +$197,000 +13% 31 Jan 2021 10-Q 11 Mar 2021 2021 Q3
Q3 2020 $1,354,000 -$301,000 -18% 31 Oct 2020 10-Q 10 Dec 2020 2021 Q2
Q2 2020 $1,523,000 -$234,000 -13% 31 Jul 2020 10-Q 14 Sep 2020 2021 Q1
Q1 2020 $1,645,000 30 Apr 2020 10-K 01 Jul 2020 2020 FY
Q4 2019 $1,518,000 31 Jan 2020 10-Q 10 Mar 2020 2020 Q3
Q3 2019 $1,655,000 31 Oct 2019 10-Q 03 Dec 2019 2020 Q2
Q2 2019 $1,757,000 31 Jul 2019 10-Q 09 Sep 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.